Marshall Wace North America L.P. - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 135 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$501,000
-94.6%
6,274
-93.4%
0.00%
-94.9%
Q2 2021$9,290,000
+92800.0%
95,380
+61835.1%
0.04%
Q1 2020$10,000
-100.0%
154
-99.9%
0.00%
-100.0%
Q1 2019$35,398,000
+261.8%
282,602
+707.8%
0.12%
+127.3%
Q2 2018$9,785,000
+132.8%
34,985
-23.6%
0.06%
+139.1%
Q4 2017$4,203,00045,7850.02%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Tao Capital Management LP 77,657$11,3428.78%
University of Wisconsin Foundation 40,133$5,861,0236.72%
Paulson & Co. 500,000$73,020,0006.53%
TCG Crossover Management, LLC 179,917$26,275,0793.87%
Avoro Capital Advisors LLC 1,555,000$227,092,2003.54%
Affinity Asset Advisors, LLC 85,000$12,413,4003.49%
Ghost Tree Capital, LLC 57,500$8,397,3002.76%
Lynwood Capital Management Inc. 5,000$730,2001.92%
MPM BioImpact LLC 40,859$5,967,0481.59%
Tri Locum Partners LP 33,761$4,930,4561.58%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders